Category	Topic	Subtopic 	Image	Image Caption	Header 1	Info1	Header2	Info2	Header3	Info3	Header4	Info4	Header5	Info5	Header6	Info6	Header7	Info7	Header8	Info8	Header9	Info9	Header10	Info10	Header11	Info11	Header12	Info12	Header13	Info13	Header14	Info14	Header15	Info15
Retina	General	Layers of the Retina	188_Retina.jpg	Layers of retina	How often do photoreceptor outer segments renew?	Every 10 days																												
Retina	General	Wavelengths	nil	nil	"[…] is most sensitive to light at what wavelength?
# Rhodopsin ^
# L cone ^
# M cone ^
# S cone ^
# Excimer laser ^
# Argon retinal laser ^
# Diode laser? ^
# Nd:YAG laser ^
# Femtosecond laser ^
---"	nil	# Rhodopsin ^	510nm (green)	# L cone ^	564-580nm	# M cone ^	534-545nm	# S cone ^	420-440nm	# Excimer laser ^	193nm (UV)	# Argon retinal laser ^	532nm (Green)	# Diode laser ^	810nm (IR)	# Nd:YAG laser ^	1064nm	# Femtosecond laser ^	1053nm										
Retina	General	Bruch's Membrane	"190_BruchsMembrane_1.gif, 190_BruchsMembrane_2.gif"	Periodic-acid Schiff (PAS) stained the retinal pigment epithelium and Bruch's membrane heavily*Normal Bruch's membrane	"# Fusion of RPE and choriocapillaris
# 5 elements? ^
# Stain with? ^
# Choroidal neovascularization occurs within Bruch’s membrane
# Outer + Inner Retinal Barriers? ^
---"	nil	# 5 elements? ^	"- Basal lamina of RPE
- Outer collagenous zone
- Elastin fibers
- Inner collagenous zone
- Basal lamina of choriocapillaris 
(a.k.a. ""Elastin sandwich"")"	# Stain with? ^	- PAS (+)	# Outer + Inner Retinal Barriers? ^	"- Outer = Bruch’s membrane
- Inner = Capillary basal lamina"																						
Retina	General	Imaging	"191_Imaging_FA_1.png, 191_Imaging_FA_3.jpg, 191_Imaging_FA_4.jpg, 191_Imaging_ICG_1.jpg, 191_Imaging_OCT_1.jpg, 191_Imaging_OCT_2.jpg"	FA showing initial pigmentation in the area of the tumor (melanoma) with extensive drusen and late leak throughout the mass*FA*Small vessel vasculitis causing cystoid macular edema - late frame fluorescein angiograph*Reticular Macular Disease - Bilateral Wet Macular Degeneration and Polypoidal Choroidal Vasculopathy – ICG*Myopic Macular Degeneration - Dry OCT OS*OCT	"# Fluorescein Angiography (FA) ^
# Indocyanine Green Angiography (ICT) ^
# Optical coherence tomography (OCT) ^
# Size of foveola? Foveal avascular zone? ^
# Location of fovea? ^
# Definitions? ^
---

"	nil	# FA ^	"1) Fluorescein sodium
- Absorbs at 465-490nm (blue)
- Emit at 520-530nm (green)
- 80% bound to plasma protein
- 90% renal excretion
2) Phases
- Choroidal phase (10-15s)
- Arterial phase (15-18s)
- Early arteriovenous phase
- Arteriovenous phase (20-25s)
- Recirculation phase (30+s)
- Late phase (fluorescein leaves retinal circulation by 10min)
3) Hyperfluorescence
- Autofluorescence (from lipofuscin)
- Transmission defect
- Leaking (increasing blurred border)
- Pooling (accumulate in anatomic space)
- Staining (fixed margins)
4) Hypofluorescence
- Blocked fluorescence
- Filling Defect"	# Indocyanine Green Angiography (ICG) ^	"- Absorbs at 805m; Emit at 835nm
- 98% bound to albumin (stays in choroidal vessels, so better for choroidal circulation)
- 5% iodine – avoid if shellfish allergy"	# OCT ^	"- Time domain: higher bandwidth = higher axial res
- Frequency/Spectral domain: faster, better signal-to-noise ratio"	# Size of: Foveola? Foveal asvascular zone? ^	"0.3mm and 0.5mm, respectively"	# Location of fovea? ^	"4mm temporal, 0.8mm inferior to optic nerve"	# Definition of macula? ^	>2 GCL layers	# Definition of fovea? ^	only cones present	# Definition for foveola? ^	ONL & GCL absent												
Retina	Choroidal Diseases	Central Serous Chorioretinopathy (CSCR)	"192_CSCR_1.png, 192_CSCR_2.png, 192_CSCR_3.png, 192_CSCR_4.jpg, 192_CSCR_5.jpg, 192_CSCR_6.jpg, 192_CSCR_7.jpg, 192_CSCR_8.jpg, 192_CSCR_9.jpg, 192_CSCR_10.jpg, 192_CSCR_11.jpg"	"CSR (Early phase FA)*CSR (Late phase FA, expansile dot)* CSR(Later phase FA, expansile dot)*CSR (OCT)*FA arterial*FA AV*FA AV*FA late*OCT*Opto*Redfree"	"# Idiopathic serous RD w/ multifocal PEDs, RPE changes & mottled atrophy
# Usually in young males
# Risks? ^
# FA & OCT? ^
# Treatment? ^
# Ddx of serous RD? ^
---"	nil	# Risks? ^	"steroids, stress, type A personality"	# FA & OCT? ^	"- FA: expansile dot (common), smokestack 
- OCT: thickened choroid (?increased hydrostatic pressure in choroid)"	# Treatment? ^	"- Observation (self-limited 3-4mo)
- Treat if >3-4mo, recurrent, permanent changes
- Laser speeds recovery, not VA outcome
- PDT (half-fluence), rifampin, spironolactone"	# Ddx of serous RD? ^	"- CNV (+leakage)
- PCV (saccular outpouchings)
- ON pit (no leakage)
- VKH / SO 
- posterior scleritis
- lymphoma
- pre-eclampsia / severe HTN 
- choroidal tumor
- toxoplasmosis / syphilis"																				
Retina	Macular Diseases	Age-Related Macular Degeneration (AMD)	"193_DryAMD_1.png, 193_DryAMD_2.jpg, 193_DryAMD_3.jpg, 193_DryAMD_5.jpg"	AMD Dry Hydrophilic Drusen and Geographic Atrophy*Hyperpigmentation of the Retinal Pigment Epithelium in Dry AMD*Basal Laminar Drusen*Reticular Pseudodrusen	"# Dry AMD
- Associated with? ^
- Drusen: Quality? Deposits? Size? ^
- Geographic Atrophy: AF? Ddx of GA? ^
# Cuticular (Basal Laminar) Drusen? ^
# Reticular Pseudodrusen? ^
---

"	nil	# Dry AMD: Associated with? ^	"age, smoking, positive family history, female, light iris, hyperopia, HTN, hypercholesterolemia"	# Drusen: Hard vs. Soft? ^	"- Hard: nodular thickening of BM of RPE
- Soft: focal PED (separation from Bruch’s)"	# Drusen: Basal Laminar vs. Linear deposits? ^	"- Electron microscopy characterization
- BLamD: between plasma & BM of RPE
- BLinD: external to BM of RPE"	# Drusen: Size? ^	"- Small <64um
- Intermediate 64-124um
- Large >124um"	# GA: AF? ^	- Decreased AF w/ ring of increased AF predict areas of GA expansion	# GA: Ddx of GA? ^	"Mitochondrial myopathies, central areolar choroidal dystrophy"	# Cuticular (Basal Laminar) Drusen? ^	"- Type of early hard drusen (age 30-40s) 
- Many small, uniform, demarcated drusen, better seen on FA with “stars-in-the-sky” appearance
- May develop large vitelliform detachment"	# Reticular Pseudodrusen? ^	"- Interlacing network of 125-250um drusen
-  First appear in superotemporal macula
-  Better seen on red-free, NOT on FA /ICG
-  “Sawtooth” subretinal deposits on OCT"												
Retina	Macular Diseases	Age-Related Macular Degeneration (AMD)	nil	nil	"Dry AMD
# Treatment: AREDS, AREDS 2, Others ^
# Epidemiology: Framingham Eye Study ^
# Experimental Models ^
---"	nil	# Treatment: AREDS ^	"- Components? 
## Vitamins C & E, beta carotene, copper, zinc
- 25% reduction in progression to advanced AMD
- 19% reduction in VA loss over 5 yrs
- Criteria? 
## Bilateral intermediate (many int or 1 large)
## Unilateral advanced AMD (wet AMD or GA)
- Avoid in smokers? 
## Beta carotene"	# Treatment: AREDS 2 ^	"- Components?
## Antioxidants w/o beta carotene, omega-3 fatty acid, xanthophylls (zeaxanthine, lutein)"	# Other Treatments ^	"- Immunomodulation: Copaxone (subQ NSAID)
- Neuroprotection: Brimonidine (inc BDNF, dec glial activation); CNTF (e.g. secreting liposomes)"	# Epidemiology: Framingham Eye Study ^	"- 6% in age >65
- 20% in age>75"	# Experimental Models ^	"- Poly (I:C)
- RIP3 -/-
- RIP1 -/-
- CX3CR1 1/1
- CCL2  -/-
- RD10"																		
Retina	Macular Diseases	Choroidal Neovascularization (CNV)	"195_CNV_1.jpg, 195_CNV_3.jpg, 195_CNV_4.jpg"	OCT of occult CNV*FA of classic CNV*FA of classic CNV	"Choroidal Neovascularization (CNV)
# Classificaton? ^
# Classic Definition? ^
---"	nil	# Classification? ^	"- Type 1
## Under RPE
- Type 2
## Between RPE + photoreceptors
- Type 3
## Retinal angiomatous proliferations (RAP)"	# Classic Definitions? ^	"- Classic CNV
## Early hyper + late leakage
- Occult CNV
## Stippled/granular early hyper + late stain
## 2 types: fibrovascular PED vs. late leakage of undetermined source
- Types
## Predominantly Classic (>49% classic)
## Minimally Classic (<49% classic)
## Occult w/o Classic (no classic)"																								
Retina	Macular Diseases	Choroidal Neovascularization (CNV)	195_CNV_2.jpg	Retinal Angiomatous Proliferation - Type III choroidal neovascular membrane	"Retinal Angiomatous Proliferation (RAP)
# Yannuzzi Classification? ^"	"- Stage 1
## Intraretinal NV / leakage
- Stage 2
## Subretinal NV + serous PED
- Stage 3
## Choroidal NV + fibrovascular PED
## FA: retinochoroidal anastamoses"																												
Retina	Macular Diseases	Wet AMD Treatments	nil	nil	"# Laser: MPS ^ 
# PDT: TAP, VIP ^
# Anti-VEGF ^
- Pegaptanib
- Ranibizumab
- Bevacizumab
- Afilbercept"	nil	# Laser: MPS ^	"- Extrafoveal & Juxtafoveal
## Laser all (AMD, POHS, idiopathic)
- Subfoveal: (only AMD studied)
## <2DD, laser
## 2-3.5DD, treat if <20/200
## >3.5DD, don’t laser
- Laser only classic, not occult
- Argon = krypton (no difference)"	# PDT: Regular vs. Reduced fluence? ^ 	"- Regular: 600mW/cm2
- Reduced: 300mW/cm2"	# PDT: TAP ^	PDT > control in classic CNV	# PDT: VIP ^	"- PDT > control in occult CNV (w/o classic)
- Small area (<4DA) and low vision (<20/30)
- PDT studies also evaluated myopia"	# Anti-VEGF: Pegaptanib (Macugen) ^	"- pegylated anti-VEGF RNA aptamer 
- binds VEGF 165
- 0.3mg"	# Anti-VEGF: Ranibizumab (Lucentis) ^	"- 48kD Fab of Mab (<50kD to cross retina)
- targets VEGF-A
- 0.3mg (DME), 0.5mg (AMD), 2mg"	# Anti-VEGF: Bevacizumab (Avastin) ^	"- full-length Mab + Fc
- targets VEGF-A
- 1.25mg, 2.5mg"	# Anti-VEGF: Aflibercept (Eylea) ^	"- ligand-binding domain of VEGFR _ + IgG Fc
- binds VEGF-A & placental-like GF
- 2mg, 4mg"												
Retina	Macular Diseases	Wet AMD Treatments: Studies	nil	nil	"# VISION ^
# MARINA ^
# ANCHOR ^
# PIER ^
# PrONTO ^
# SUSTAIN ^
# HORIZON ^
# CATT ^
# FOCUS ^
# SUMMIT (MONT BLAN, DENALI, EVEREST) ^
# CABERNET ^
# RADICAL ^
# VIEW 1 & 2 ^
# HARBOR ^"	nil	# VISION ^	"- Macugen q6wks x 48wks > sham
- Improved VA in all CNV"	# MARINA ^	"- Lucentis q4wks x 2yrs > sham
- Minimally-classic or occult w/o classic CNV"	# ANCHOR ^	"- Lucentis q4wks x 2yrs > PDT q3mo PRN
- Predominantly-classic CNV"	# PIER ^	"- Lucentis q4wks x 3 then q12wks
- Steady decline after 3mo c/w q4wks"	# PrONTO ^	"- Lucentis q4wks x 3 then PRN (VA loss + fluid, CRT inc, mac hem, new cl CNV, persistent fluid s/p inj)
- Comparable to q4wks; 5.6inj/yr, but q4wk visits
"	# SUSTAIN ^	"- Lucentis q4wks x 3 then PRN (VA loss, CRT inc)
- Comparable to q4wks; 5.3inj/yr, but q4wk visits
"	# HORIZON ^	"- MARINA/ANCHOR/FOCUS pts  tx w/ PRN Lucentis q4wks s/p 2yrs
- Continued less frequent dosing -> VA loss"	# CATT ^	"- Lucentis = Avastin q4wks or PRN in VA (<5letter diff)
- Lucentis > Avastin q4wks or PRN in OCT fluid (~10%)
- Avastin > Lucentis in adverse events (24 vs 19%)"	# FOCUS ^	"- Lucentis + PDT > PDT alone
- Predominantly-classic CNV"	"# SUMMIT (MONT BLANC, DENALI, EVEREST) ^"	"- Lucentis + PDT = Lucentis alone
- Except IPCV (Lucentis + PDT > Lucentis)"	# CABERNET ^	- Lucentis + epimacular brachy vs Lucentis	# RADICAL ^	"- Lucentis + PDT + Dexamethasone vs Lucentis
"	# VIEW 1 & 2 ^	- Eylea q1mo x 3 -> q2mo = Lucentis q1mo	# HARBOR ^	- Lucentis 0.5mg q4wks vs PRN vs 2mg q4wks vs PRN
Retina	Macular Diseases	Other Causes of CNV: Myopic Degeneration	"198_CNV_MyopicDegeneration_1.jpg, 198_CNV_MyopicDegeneration_2.png"	Myopic Contour on OCT*Posterior Staphyloma and Geographic Atrophy Myopic Degeneration	"# High vs Pathologic myopia? ^
# Findings? ^
# Treatment? ^
---"	nil	# High vs Pathologic myopia? ^	"- High: >-6.00D, >26.5mm
- Pathologic: >-8.00, >32.5mm"	# Findings? ^	"‘- Lacquer cracks
## can cause round, deep SRH that clears spontaneously (not CNV)
- Forster-Fuchs spots
## dark spots from subretinal or intraretinal RPE hyperplasia
- Posterior staphyloma
- Cobblestone, lattice, cystoid degeneration"	# Treatment? ^	"‘- Subfoveal: PDT (VIP), anti-VEGF
- Extra/juxtafoveal: anti-VEGF, no data for laser"																						
Retina	Macular Diseases	Other Causes of CNV: Presumed Ocular Histoplasmosis Syndrome (POHS)	199_CNV_POHS.png	Presumed Ocular Histoplasmosis Syndrome	"# Findings? ^
# Geography? ^
# Treatment? ^
# Prognosis? ^
---"	nil	# Findings? ^	"‘- Punched-out “histo spots”
- Peripapillary atrophy
- CNV (peripapillary)
- No vitritis"	# Geography? ^	Ohio-Mississippi River Valley	# Treatment? ^	"‘- Extra/juxtafoveal: laser (MPS), anti-VEGF
- Subfoveal: PDT, steroids, anti-VEGF"	# Prognosis? ^	44% severe VA loss (>6 lines) in 5 yrs																				
Retina	Macular Diseases	Other Causes of CNV: Angioid Streaks	"200_CNV_AngioidStreaks_1.jpg, 200_CNV_AngioidStreaks_2.jpg"	Angioid Streaks*PXE with Angioid Streaks	"# Breaks in Bruchs membrane
# Minor trauma may cause bleeding
# Causes? (PEPSI) ^
# Treatment? ^
---"	nil	# Causes? (PEPSI) ^	"‘- PXE
## Peau d’orange fundus
## Depigmented subretinal “crystalline spots” or “comet tail”
## Peripheral atrophic spots
## Optic nerve drusen
## Plucked chicken skin
## GI hemorrhages (life threatening)
- Ehlers-Danlos syndrome  
## Hyperextensible joints, scoliosis
## Blue sclera, brittle cornea
- Paget’s disease
## Long bone fractures
- Sickle cell disease
- Idiopathic (50%)"	# Treatment? ^	- Anti-VEGF; laser (extrapolated from MPS)																								
Retina	Choroidal Diseases	Polypoidal Choroidal Vasculopathy (PCV)	"201_PCV_IPCV_1.jpg, 201_PCV_IPCV_2.jpg"	"Idiopathic PCV - FA*Idiopathic PCV - ICG, Polyp Visible"	"# Multifocal, recurrent serous PEDs
# Saccular choroidal outpouchings
# More common in? ^
# FA? ^
# Treatment? ^
---"	nil	# More common in? ^	"‘- African-Caribbeans & Asians (M>F, mostly unilateral)
- Also occurs in Caucasians & Blacks (F>M, mostly bilateral, peripapillary)"	# FA? ^	"‘- Early hyperfluorescent polyps and hypofluorescent halos
- Polyps better seen on ICG"	# Treatment? ^	"‘- Anti-VEGF, PDT, or combined
- Only disease in SUMMIT trial to have improved response to combined anti-VEGF + PDT"																						
Retina	Vitreomacular Interface	Vitreoretinal Interface: Epiretinal Membrane (ERM)	"202_VitreoretinalInterface_ERM_1.jpg, 202_VitreoretinalInterface_ERM_2.jpg"	Epiretinal Membrane*Epiretinal Membrane with Pseudohole	"# Can be idiopathic or secondary to vascular occlusions, inflammation, surgery, trauma, or retinal breaks (allows RPE migration onto retina)
# Stable (>75% maintain >20/50)
# Treatment? ^"	"- PPV/MP if VA <20/50 or severe metamorphopsia
- 66-75% has VA improvement
- 80% get cataracts
- 2-7% recurs"																												
Retina	Vitreomacular Interface	Vitreoretinal Interface: VMT	202_VitreoretinalInterface_ERM_2.jpg	VMT	"# VMA with traction
# Treatment? ^"	"‘- PPV/MP (risks unknown)
- Ocriplasmin (microplasmin)
## Truncated form of plasmin
- MIVI-TRUST Study:
## OCP > placebo in VMA resolutn (26 vs 12%)
## OCP > placebo in MH closure (40% vs 25%)
## OCP > placebo in VA gain    (12% vs 9%)
## Better if phakic, no ERM"																												
Retina	Vitreomacular Interface	Macular Holes	203_MacularHoles_OCT.jpg	Macular Hole - OCT	"Idiopathic Macular Hole
# Clinical test? ^
# Stages (antiquated)? ^
# New grading system? ^
# Treatments? ^
# PPV Treatment success? ^
# Treatment for traumatic MH? ^
# What is a Pseudohole? ^
# What is a Lamellar Hole? ^
---"	nil	# Clinical test? ^	Watzke-allen test	# Stages (antiquated)? ^	"‘- Stage 1
## 1A (pseudocyst); 1B (outer layer loss) 
## 50% spontaneously resolve (no surgery)
- Stage 2
## Full-thickness hole <400um
- Stage 3
## Full-thickness >400um + elevated rim
- Stage 4
## Hole with PVD"	# New grading system? ^	"‘- Small <250um
- Medium 250-400um
- Large >400um"	# Treatments? ^	"‘- Jetrea (if <250um & VMA present)
- PPV (if >250um) + ILMP (if >400um)"	# PPV Treatment success? ^	"‘- 92% closure ; 50% if re-op
- short-acting gas (SF6 or 10% C3F8)
- ILMP (_ closure) if >400um
- Face down (3 days; _ closure if >400um)"	# Treatment for traumatic MH? ^	Observation (no traction; spontaneous closure ~2 mo)	# What is a Pseudohole? ^	"‘- Appearance of hole w/ steep walls
- Caused by vascular tortuosity around macula"	# What is a Lamellar Hole? ^	"‘- Thin layer of retina lifted w/ walls “bulging out”
- Maybe precursor or resolved macular hole"												
Retina	Vascular Diseases	Purtscher's Retinopathy	"204_Heme_PurtschersRetinopathy_1.jpg, 204_Heme_PurtschersRetinopathy_2.jpg"	Purtscher's Retinopathy - Motor Vehicle Accident*Purtscher's Retinopathy - 19yo Female After Pregnancy	# Terson Syndrome ^	nil	# Terson Syndrome ^	"‘- Vitreous + subhyaloid heme caused by acute rise in ICP
- 30% subarachnoid or subdural hemorrhage have intraocular heme
- Treatment?
## PPV (works well)"																										
Retina	Vitreous	Vitrous Hemorrhage	"204_TersonSyndrome_1.jpg, 204_TersonSyndrome_2.png"	Preretinal Heme*Subarachnoid Hemorrhage	"# Ochre Membrane ^
# Synchysis scintillans ^
# Purtscher Retinopathy ^"	nil	# Ochre Membrane ^	Heme on posterior surface of detached vitreous	# Synchysis scintillans ^	"Refractile, yellow cholesterol crystals in vitreous after resolution of VH"	# Purtscher Retinopathy ^	"‘- Usually peripapillary hemorrhages, cotton-wool spots, & edema after acute compression injuries to head or thorax
- FA: arteriolar leakage
- Etiology?
## injury-induced complement activation & granulocyte aggregation
- Causes of Purtscher-like Retinopathy?
## Acute pancreatitis
## SLE (Lupus)
## Amniotic fluid embolism
## Fat embolism
## Renal failure
## Retrobulbar anesthesia"																						
Retina	Macular Diseases	Other Maculopathies	"205_Maculopathies_AMN.png, 205_Maculopathies_SolarRetinopathy.jpg, 205_Maculopathies_UAIM.png"	Acute Macular Neuroretinopathy - Spot in Vision OS*Solar Retinopathy*Unilateral Acute Idiopathic Maculopathy (UAIM)	"# Solar Maculopathy ^
# UAIM / Unilateral Acute Idiopathic Maculopathy ^
# AMN / Acute Macular Neuroretinopathy ^
---"	nil	# Solar Maculopathy ^	"‘- Small yellow foveolar spot that evolves to a small MH
- OCT: loss of IS/OS \\\ band + small  \\\discrete defect
- Caused by sun-gazing or arc welding, usu. occurring ~2wks after exposure
- Increased risk from psoralen or tetracycline
- VA usu. returns to normal"	# UAIM / Unilateral Acute Idiopathic Maculopathy ^	"‘- Acute vision loss usu. in young adult
- Grayish RPE thickening +/- serous RD +/- vitritis
- FA: early hyper/hypo + late pooling
- OCT: outer retinal defects
- Spontaneously improve in weeks, OCT resolves"	# AMN / Acute Macular Neuroretinopathy ^	"‘- Subacute vision loss + paracentral scotomas
- Usu. unilateral
- Permanent or transient
- Dark triangular macula patches at outer retina
- OCT: IS/OS defects
- Dx: multifocal ERG"																						
Retina	Vascular Diseases	"Hypertension: Hypertensive Retinopathy, Macroaneurysms"	"206_Hypertension_HypertensiveRetinopathy.jpg, 206_Hypertension_Macroaneurysm_1.png, 206_Hypertension_Macroaneurysm_2.png"	Hypertensive Retinopathy*Ruptured Retinal Arterial Macroaneurysm - Submacular Hemorrhage*Retinal Arterial Macroaneurysm	"# Scheie classification? ^
# Can cause BRAO, BRVO, CRVO
# Treatment? ^
# Macroaneurysms ^
---"	nil	# Scheie classification? ^	"‘- Grade 0: no change
- Grade 1: trace arterial narrowing
- Grade 2: frank arterial narrowing + focal irregularities
- Grade 3: grade 2 + retinal hemorrhages/exudates
- Grade 4: grade 3 + disc swelling"	# Treatment? ^	Laser if macula involved	# Macroaneurysms ^	"‘- 2/3 from HTN retinopathy; also CRVO
- Tx: laser"																						
Retina	Vascular Diseases	Hypertension: Hypertensive Choroidopathy	206_Hypertension_HypertensiveChoroidopathy.png	Hypertensive Choroidopathy - Pheochromocytoma	"# Usually occurs w/ acute HTN ^
# Findings? ^
# FA? ^
# DDx? ^
---"	nil	# Usually occurs w/ acute HTN ^	"‘- Preeclampsia or eclampsia
- Renal disease
- Pheochromocytoma
- Malignant HTN"	# Findings? ^	"‘- Elschnig spots
- Siegrist streaks
- Serous RD"	# FA? ^	"‘- early focal choroidal hypoperfusion
- late subretinal leakage"	# DDx? ^	"‘- Vaso-occlusive dx (TTP, ITP, DIC) 
- Inflammatory dx (GCA, Wegener’s"																				
Retina	Vascular Diseases	Diabetic Retinopathy	"207_DiabeticRetinopathy_CSME.jpg, 207_DiabeticRetinopathy_NPDR.jpg, 207_DiabeticRetinopathy_PDR_1.png, 207_DiabeticRetinopathy_PDR_2.png"	Clinically Significant Diabetic Macular Edema with Exudates*Nonproliferative Diabetic Retinopathy*Proliferative Diabetic Retinopathy Type I Diabetic*Proliferative Diabetic Retinopathy	"# NPDR 
- Mild
- Moderate
- Severe ^
- Very severe ^
# CSME ^
# PDR
- Early
- High risk ^
# Macular Ischemia ^
---"	nil	"# NPDR 
- Mild
- Moderate
- Severe ^"	"## 4:2:1 rule, any one of:
- 4 quads: IRH + Mas
- 2 quads: venous beading
- 1 quad: IRMA
## 15% chance of progression to high-risk PDR within 1 year
## CWS are NOT predictive"	- Very severe ^	"## Any 2 of the 4:2:1 rule
## 45% chance of progression to high-risk PDR within 1 year"	# CSME ^	"- Any edema within 500_m of fovea
- Hard exudates within 500_m of fovea + adjacent edema
- Edema >1 disc area in size within 1 disc diameter of fovea"	"# PDR:
- Early
- High risk ^"	"## Any NVD with VH
## 1/4-1/3 disc area NVD (≥standard photo 10A)
## 1/2 disc area NVE with VH (standard photo 7)"	# Macular Ischemia ^	"‘- FA: microaneurysms at margins of zone of capillary nonperfusion
- FAZ enlargement >1000um usu. associated with visual loss"																		
Retina	Vascular Diseases	Retinal Lasers	208_RetinalLasers_PRP.png	Panretinal (Scatter) Photocoagulation (Fresh)	"# Panretinal Photocoagulation (PRP)
- >1200 spots, 500um, 0.1s, 1/5 apart
- Side effects? ^
- Avoid 3:00 & 9:00? ^
- PRP before CE/IOL if view clear
# Focal / Grid Laser ^
# ETDRS ^
# DRS
- Argon/Xenon laser for? ^
- Defined high-risk PDR
- PRP for high-risk PDR: 50% reduction in severe VA loss x 5 yrs
---"	nil	"# Panretinal Photocoagulation (PRP)
- Side effects? ^"	"## Lost of peripheral vision
## Decrease in night or color vision
## Glare, photopsias
## Worsens macular edema"	- Avoid 3:00 & 9:00? ^	## Pain from long ciliary nerves	# Focal / Grid Laser ^	"- 50-100um, 0.1s
- Whiten MA for focal or >1 spot size for grid
- Treat CSME before PRP for hrPDR
- Treat CSME before CE/IOL"	# ETDRS ^	"- Early PRP (for severe NPDR)
## Small improvement in risk of severe VA loss (<5/200) x 4 mo
## Most effective in DM2 patients
- Focal laser (for CSME)
## 50% reduction of mod VA loss in CSME over 3 yrs (15% vs 30%)
## Increased chance for visual GAIN
## Reduced retinal thickening
- ASA
## 650mg/day did not affect rate of retinopathy or vision loss"	"# DRS
- Argon/Xenon laser for? ^"	"## severe NPDR OU 
## high-risk PDR in one eye"																		
Retina	Vascular Diseases	Diabetic Macular Edema	"209_DiabeticMacularEdema_1.jpg, 209_DiabeticMacularEdema_2.jpg, 209_DiabeticMacularEdema_3.jpg"	Diabetic macular edema*Diabetic Patient with Macular Edema and Blood Pressure*OCT	"# Posterior subtenon triamcinolone ^
# Intravitreal steroids ^
# Focal laser ^
# READ-2 ^
# RISE & RIDE ^
---"	nil	# Posterior subtenon triamcinolone ^	Improves VA up to 1 year	# Intravitreal steroids ^	"‘- Improves VA/CSME up to 2 yrs
- Not as effective as focal per DRCR.net
- Pseudophakic: triamcinolone+laser = Lucentis+laser, but more glaucoma
- Vision gain not dependent on amt of initial edema
- Increased risk of glaucoma/cataract"	# Focal laser ^	‘- Improves CSME long term	# READ-2 ^	"‘- Lucentis vs focal/grid vs both
- At 6mo: Lucentis = both > focal/grid
- At 24mo, all had Lucentis PRN; all improved"	# RISE & RIDE ^	"‘- Lucentis 0.3 vs 0.5 vs sham, qmonth
- At 24mo: Lucentis 0.3 = 0.5 > sham
- At 36mo: Lucentis 0.3 = 0.5 > sham
- Slightly greater thromboembolic events with 0.5mg dosing"																		
Retina	Vascular Diseases	"Diabetic Retinopathy: Management (DCCT, UKPDS, DRVS)"	nil	nil	"# DCCT ^
# UKPDS ^
# DRVS ^
---"	nil	# DCCT ^	"‘- Intensive > conventional glycemic control in DM1 pts, reduces onset & progression of DR & macular edema"	# UKPDS ^	"‘- Intensive > conventional glycemic control in DM2 pts, reduces onset & progression of DR
- Intensive BP control slowed progression of DR 
- No difference bet. ACEi & BB"	# DRVS ^	"‘- Early (<6 mo) vs. late (>1 yr) PPV for non-clearing VH 
- Early PPV improved VA outcome in DM1, not DM2 patients
- Indications for PPV
## Dense non-clearing VH
## TRD threatening macula
## Combined TRD/RRD
## Diffuse DME w/ traction
## Recurrent VH despite max PRP"																						
Retina	Vascular Diseases	Diabetic Retinopathy: Management (DRCR network)	nil	nil	DRCR network	211_Table.png																												
Retina	Vascular Diseases	Diabetic Retinopathy: Screening and Monitoring	nil	nil	"# Pregnant ^
# Onset 0-30 years old ^
# Onset >31 years old ^
# If mild NPDR
# Moderate NPDR
# Severe NPDR ^
# Severe NPDR + CSME ^
# PDR ^
---"	nil	# Pregnant ^	"‘- Before conception or in 1st trimester,  q3mo"	# Onset 0-30 years old ^	"‘- Within 5 yrs, then yearly"	# Onset >31 years old ^	"‘- At diagnosis, then yearly"	# If mild NPDR	‘- Every 9 months	# Moderate NPDR	‘- Every 6 months	# Severe NPDR ^	‘- Every 4 months	# Severe NPDR + CSME ^	‘- Every 2-4 months	# PDR ^	‘- Every 2-3 months												
Retina	Vascular Diseases	Diabetic Retinopathy: Epidemiology and Other Risk Factors	nil	nil	"# Epidemiology ^
# Other Risk Factors ^
# Associations with Diabetes ^
---"	nil	# Epidemiology ^	"‘- Based on WESDR, after 20 years:
## DM1 – 99% w/ DR
## DM2 – 60% w/ DR
      (Wisconsin white population)"	# Other Risk Factors ^	"‘- In patients with HTN, intensive BP control may worsen retinal perfusion
- In patients with carotid dx, mild-mod carotid dx may worsen ischemia"	# Associations with Diabetes ^	"‘- Type II juxtafoveal telengiectasis
## Acquired; bilateral
## Abnormal GTT test
- PSC cataracts
- Lacy vacuolization of the iris
- Thickened basement membranes"																						
Retina	Vascular Diseases	Radiation Retinopathy	"213_RadiationRetinopathy_1.jpg, 213_RadiationRetinopathy_2.jpg"	Radiation Retinopathy*Choroidal Melanoma with Radiation Retinopathy	"# May result from external beam radiation or plaque brachytherapy
# Usual onset? ^
# Usual amount of radiation? ^
# Clinical appearance similar to diabetic retinopathy
# Treatment? ^
---"	nil	# Usual onset? ^	"‘- ~18mo s/p external XRT
- Earlier for brachytherapy"	# Usual amount of radiation? ^	‘- 30-35Gy (min 15Gy)	# Treatment ^	"‘- Similar to diabetic retinopathy
- Consider Avastin q3month for prophylaxis"																						
Retina	Vascular Diseases	Sickle Cell Retinopathy	214_SickleCellRetinopathy_1.jpg	Sickle Cell Retinopathy	"“African-American with vitreous hemorrhage?”
# Nonproliferative
- Salmon patch
## Intraretinal hemorrhage after arteriolar occlusion
- Iridescent spots
## Old resorbed heme
- Black sunburst
## RPE hypertrophy, hyperplasia
# Proliferative
- Stage 1: peripheral arteriolar occlusion
- Stage 2: peripheral AV anastomoses
- Stage 3: preretinal sea fan NV (posterior border of nonperfusion; may autoinfarct and turn white)
- Stage 4: Vitreous hemorrhage
- Stage 5: Tractional RD
# Hemoglobinopathy? ^
# Gene defect? ^
# Avoid carbonic anhydrase inhibitors
# Other Eye findings? ^
# Treatment? ^
---"	nil	# Hemoglobinopathy? ^	"‘- SC worst ocular Sx (SC>Sthal>SS>SA)
- SS worst systemic Sx"	# Gene defect? ^	‘- Val sub for glu acid at 6th position on B-polypeptide chain	# Other Eye findings? ^	"‘- Angioid streaks
- Comma sign (segmented conj vessels)"	# Treatment? ^	"‘- Scatter laser to ischemic retina
- PPV precautions (avoid encircling SB or taking down EOMs, avoid epi in local anesthetic, ensure O2 & hydration)"																				
Retina	Vascular Diseases	Eales disease	"215_EalesDisease_1.jpg, 215_EalesDisease_2.jpg"	Eales Disease*Eales Disease - FA	"“Young man with idiopathic bilateral peripheral NV?”
# Idiopathic obliterative perivasculitis of peripheral retina
# Bilateral peripheral NV + VH
# Young males
# Associated with? ^
# Endemic in? ^
---"	nil	# Associated with? ^	‘- TB hypersensitivity	# Endemic in? ^	‘- India																								
Retina	Pediatric Disorders	DDx Pediatric Leukocoria 	216_PediatricLeukocoria_Retinoblastoma_2.png	Retinoblastoma	"# Retinoblastoma
# PFV
# ROP
# Cataract
# Coloboma of choroid or optic disc
# Uveitis
# Toxocariasis
# Congenital retinal folds
# Coats disease
# Organized vitreous hemorrhage
# FEVR
# Norrie disease
# Retinal detachment
# Myelinated nerve fibers"																													
Retina	Pediatric Disorders	Retinoblastoma	"217_Retinoblastoma_1.jpg, 217_Retinoblastoma_2.jpg, 217_Retinoblastoma_3.gif"	Retinoblastoma*Retinoblastoma rosette*Retinoblastoma Histopathology	"“Most common primary intraocular malignancy in children”
# Rb Inheritance? ^
# Signs? ^
# Path? ^
# Prognosis: ^
# Reese-Ellsworth classification: ^
# Trilateral retinoblastoma? ^
# Common secondary malignancies? ^
---"	nil	# Rb Inheritance? ^	"‘- 1/3 bilateral, 2/3 unilateral
- 1/3 hereditary, 2/3 sporadic"	# Signs? ^	"‘- Leukocoria or strabismus usu. before age 3
- Early tumor in macula, later in periphery
- LDH aqueous:plasma ratio >1.0
- Calcium on U/S or CT"	# Path? ^	"‘- Tumor grows around blood vessels
- Flexner-Wintersteiner rosette (RB specific)
- Homer Wright (also other neuroblastomas)
- Fleurette (Photoreceptor differentiation)"	# Prognosis: ^	"‘- Good with early tx; spontaneous regression rare
- Enucleation, radiation, chemo, cryo, laser"	# Reese-Ellsworth classification: ^	"- Predicts visual prognosis, NOT survival"	# Trilateral retinoblastoma? ^	‘- Bilateral tumor plus pineal gland	# Common secondary malignancies? ^	"‘- Osteosarcoma, malignant melanoma"														
Retina	Pediatric Disorders	Retinoblastoma	nil	nil	International Classification of Intraocular Retinoblastoma	218_Table.png																												
Retina	Pediatric Disorders	Retinoblastoma	219_Retinoblastoma_Retinocytoma.png	Retinocytoma - Retinoma - Regressed Retinoblastoma	219_Table.png	nil	# Retinocytoma	"‘- Also arises from Rb mutation, but benign
- Occurs in siblings with retinoblastoma
- May undergo malignant transformation (rare)"																										
Retina	Pediatric Retina	Persistent Fetal Vasculature (PFV or PHPV)	"220_PFV_1.png, 220_PFV_2.jpg"	PHPV*Persistent hyperplastic primary vitreous	"“Newborn with unilateral leukocoria and microphthalmos”
# Failure of hyaloid vasculature to regress
# Inheritance? ^
# Signs? ^
# Prognosis? ^
# Location of Mittendorf dot? ^
---"	nil	# Inheritance? ^	‘- Non-hereditary	# Signs? ^	"‘- Unilateral
- Microphthalmos (disorganized)
- Fibrovascular sheath behind lens contracts to elongate ciliary processes
- Fibrovascular stalk from disc to posterior lens capsule
- Cataract
- Glaucoma (shallow AC + angle closure)
- RD and intraocular hemorrhage
- Retina may extend to pars plicata
- No systemic defects"	# Prognosis? ^	‘- Depends on degree of retinal involvement	# Location of Mittendorf dot? ^	- Inferonasal																				
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		
																																		